Project Grant F30DA063315

Award Date 10/10/25
Completion Date 9/30/30
Dollars Obligated $80K
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Utah, USA
Similar Awards
This $242,061 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279) establishes an interdisciplinary clinical pain research training program at Mass General Brigham (MGB) in Boston. The program will support 8-12 postdoctoral fellows over 5 years, providing protected research time and dedicated training to expand the pool of early-career investigators capable of launching successful clinical...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a 5-year, $2,726,432 research study on co-use of cannabis and prescription opioids among emerging adults in medical settings. The study will enroll emerging adults aged 18-25 who either have no history of cannabis use or have used cannabis in the past month and are prescribed an opioid for acute pain management. Participants will be followed...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $2,884,007 to the University of California, San Diego (UCSD) to investigate mechanisms of intra- and inter-individual pain variability in patients with comorbid chronic low back pain (CLBP) and major depressive disorder (MDD). The research aims to generate individualized prediction models of momentary pain intensity using ecological momentary...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $146,922 to Indiana University to evaluate the association between general chronic pain liability and clinically recognized substance use. The project aims to clarify the underlying mechanisms linking chronic pain and substance use disorders, accounting for heterogeneity across and comorbidity among chronic pain conditions, as well as...
This federal Project Grant award in the amount of $351,097 was provided by the National Institute of Neurological Disorders and Stroke (NINDS), which is part of the National Institutes of Health (NIH). The grant was awarded under the NIH's Drug Use and Addiction Research Programs (CFDA 93.279) to establish a rigorous and supportive interdisciplinary training program in clinical pain research at Mass General Brigham (MGB) in Boston. The program will support a diverse pool of 8 postdoctoral...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $290,312 to The Washington University in St. Louis to develop a postdoctoral training program called "Promoting Excellence through Pain and Addiction Research Enhancement (PREPARE)". The PREPARE program aims to recruit and train early career investigators to conduct clinical research on the intersection of...
This National Institutes of Health National Institute on Drug Abuse Project Grant award of $234,364.35 supports research from March 1, 2021 through August 31, 2022 at clinical practices of the University of Pennsylvania located in Pennsylvania. The research aims to characterize a nociception-active basolateral amygdala to anterior cingulate cortex circuit that contributes to affective-attention pain behaviors, and determine its overlap with endogenous mu opioid receptor systems. The grant also...
This federal Project Grant award, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279), is focused on developing novel methods for selectively stimulating nociceptors (pain receptors) and measuring the brain's nociceptive-specific response in both healthy individuals and those with the chronic pain condition fibromyalgia. The $2,314,276 award to Emory University will fund the creation of a new...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $118,457 to The Trustees of the University of Pennsylvania to conduct research aimed at harnessing the genetics of chronic pain to inform the development of non-addictive analgesic medications. The 4-year project, starting on April 15, 2025, will characterize the genetic architecture underlying chronic pain liability and addiction, estimate...
This Project Grant award of $767,506 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) is funding research to leverage integrative modeling and AI-based tools to develop safer opioid medications. The goal is to elucidate the mechanistic basis of opioid efficacy and inform the design of novel, safer opioid therapeutics. The research team at the Icahn School of Medicine at Mount Sinai will use a Bayesian inference framework to...

UNDERSTANDING PAIN EMBODIMENT AND OPIOID MISUSE RISK IN CHRONIC PAIN USING NEUROIMAGING - PROJECT ABSTRACT THE OPIOID CRISIS REMAINS AN ONGOING PUBLIC HEALTH CONCERN AS ANNUAL DEATHS DUE TO OPIOID OVERDOSE REMAIN AT RECORD-HIGH LEVELS. CHRONIC PAIN CONTRIBUTES TO BOTH NON-FATAL AND FATAL OPIOID OVERDOSES, AND THE LACK OF EFFECTIVE AND SAFE NON-OPIOID OPTIONS FOR LONG-TERM PAIN MANAGEMENT IS A SIGNIFICANT BARRIER TO THE TREATMENT OF SUBSTANCE USE DISORDERS. THERE IS AN URGENT NEED TO BETTER UNDERSTAND THE FACTORS LINKING CO-OCCURRING PAIN AND SUBSTANCE USE TO POOR FUNCTIONAL OUTCOMES, SUCH AS OVERDOSE AND PAIN-RELATED SUICIDALITY. BOTH THE SENSORY AND AFFECTIVE COMPONENTS OF CHRONIC PAIN ARE ESSENTIAL TO CONSIDER AS BOTH CONTRIBUTE TO THE PROCESS OF PAIN EMBODIMENT. PAIN EMBODIMENT IS A PART OF THE CHRONIC PAIN EXPERIENCE THAT IS CHARACTERIZED BY A TENDENCY TO APPRISE BODILY SENSATIONS AS A THREAT TO BODILY INTEGRITY. CHRONIC PAIN PATIENTS WITH HIGH PAIN EMBODIMENT MAY EXPERIENCE MORE PAIN-RELATED ANXIETY AND MAY BE MORE MOTIVATED TO USE OPIOIDS AS A SAFETY-SEEKING BEHAVIOR TO ESCAPE PAIN- RELATED DISTRESS. HERE, WE PROPOSE TO CHARACTERIZE PAIN EMBODIMENT AND HOW IT RELATES TO RISK FOR OPIOID MISUSE AND BRAIN NETWORK CHANGES AS MEASURED BY RESTING-STATE FUNCTIONAL MAGNETIC RESONANCE IMAGING (FMRI). WE WILL STUDY HEALTHY INDIVIDUALS, INDIVIDUALS WITH CHRONIC PAIN, AND INDIVIDUALS RECOVERED FROM CHRONIC PAIN WITH A STATE- OF-THE-ART IMAGING PROTOCOL AND A COMPREHENSIVE SET OF PAIN AND CLINICAL MEASURES. OUR CENTRAL HYPOTHESIS IS THAT, IN CHRONIC PAIN, PAIN EMBODIMENT INCREASES THE RISK FOR OPIOID MISUSE AND THAT THIS RELATIONSHIP IS REFLECTED IN NETWORKS SHARED BY ADDICTION AND CENTRAL PAIN PROCESSING: THE DEFAULT MODE NETWORK (DMN) AND THE SALIENCE NETWORK (SN). AIM 1 WILL IDENTIFY CONCEPTS OF PAIN EMBODIMENT THAT RELATE TO OPIOID MISUSE RISK. AIM 2 WILL DETERMINE HOW PAIN EMBODIMENT AND OPIOID MISUSE RISK ARE REFLECTED IN FUNCTIONAL CONNECTIVITY CHANGES IN THE DMN AND SN. AIM 3 WILL DETERMINE HOW PAIN EMBODIMENT AND OPIOID MISUSE RISK INFLUENCE CONCENTRATIONS OF PROTON BRAIN METABOLITES IN THE ANTERIOR CINGULATE CORTEX, A MAJOR HUB OF THE SN. TOGETHER, THIS PROPOSAL WILL ILLUMINATE HOW PAIN EMBODIMENT IS REFLECTED BY CHANGES IN CENTRAL PAIN PROCESSING AND OFFER NOVEL INSIGHTS INTO THE MECHANISMS CONTRIBUTING TO POOR FUNCTIONAL OUTCOMES IN CO-OCCURRING CHRONIC PAIN AND OPIOID MISUSE. AN INTERDISCIPLINARY TEAM OF MENTORS WILL PROVIDE TRAINING IN CLINICAL AND PSYCHOLOGICAL BEHAVIORAL MEASURES REGARDING CHRONIC PAIN AS WELL AS TRAINING IN MAGNETIC RESONANCE IMAGING METHODS, INCLUDING ACQUISITION AND DATA ANALYSIS. THIS TRAINING WILL BE COMPLEMENTED BY CLINICAL MENTORSHIP IN PSYCHOLOGY AND PHYSICAL MEDICINE AND REHABILITATION. THIS TRAINING PLAN WAS DEVELOPED IN COLLABORATION WITH MY SPONSOR AND CO-SPONSOR TO COMPLETE THE CENTRAL GOALS OF CONDUCTING INDEPENDENT, COLLABORATIVE RESEARCH; ADVANCING COMMUNICATION AND GRANT-WRITING SKILLS; EFFECTIVELY MENTORING AND TEACHING TRAINEES IN A SUPPORTIVE ENVIRONMENT; AND HONING CLINICAL SKILLS IN PREPARATION FOR THE RETURN TO MEDICAL SCHOOL. THIS TRAINING IS IDEAL FOR A FUTURE PHYSICIAN-SCIENTIST WITH THE GOAL OF IMPROVING PATIENT CARE AT THE INTERSECTION OF TRANSLATIONAL RESEARCH AND THE CLINICAL MANAGEMENT OF CO- OCCURRING SUBSTANCE USE DISORDERS AND CHRONIC PAIN CONDITIONS.

Posted 4/11/25